Reply to Misleading Impact of Mitral Regurgitation on the Evaluation of Left Ventricular Contractile Function in Heart Failure With Preserved Ejection Fraction.

J Card Fail

Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Cardiothoracic Department, Civil Hospitals, Brescia, Italy. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2024.04.013DOI Listing

Publication Analysis

Top Keywords

reply misleading
4
misleading impact
4
impact mitral
4
mitral regurgitation
4
regurgitation evaluation
4
evaluation left
4
left ventricular
4
ventricular contractile
4
contractile function
4
function heart
4

Similar Publications

Reply to Misleading Impact of Mitral Regurgitation on the Evaluation of Left Ventricular Contractile Function in Heart Failure With Preserved Ejection Fraction.

J Card Fail

August 2024

Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Cardiothoracic Department, Civil Hospitals, Brescia, Italy. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • Health misinformation on social media can lead to serious health issues, but there's limited research on effective interventions to tackle it in real time.
  • This study introduces infodemiologists, trained professionals applying evidence-based intervention techniques to counter misinformation about COVID-19 vaccines on Facebook.
  • The research monitored interactions on posts with misinformation across three regions, evaluating the effectiveness of infodemiologists' interventions through engagement metrics like replies and reactions, using statistical methods to analyze the impact.
View Article and Find Full Text PDF

Since the release of the DESTINY-Breast04 (DB-04) trial findings in June 2022, the field of pathology has seen a renaissance of HER2 as a predictive biomarker in breast cancer. The trial focused on patients with metastatic breast cancer who were classified as "HER2-low," i.e.

View Article and Find Full Text PDF

Reply to: Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?

Nat Rev Rheumatol

October 2023

Division of Rheumatology, St Joseph's Health Care, London, Ontario, Canada.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!